Company: PETVW
Filing Date: 2025-05-07
Form Type: 8-K
Source: 0001641172-25-008992
Chunk: 0

Company: PetVivo Holdings, Inc.
Filing Date: 2025-05-07
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item      Unregistered                 

On
May 6, 2025, PetVivo Holdings, Inc., including its wholly-owned subsidiary PetVivo Animal Health, Inc., (collectively the “ Company”,
“we” and “us”) received Two Hundred Thousand Dollars ($200,000) pursuant to the partial exercise of a Purchase
Option provided by the Company to an Investor as identified in a Subscription Agreement entered into on March 26, 2025 (the “ Option
Investment”). Upon receipt of the Option Investment the Company agreed to extend the Purchase Option for an additional thirty (30)
days, thereby providing for the expiration of the Purchase Option to occur on June 26, 2025 rather than May 27, 2025. The extension of
the Purchase Option for an additional thirty (30) days provides the Investor additional time to invest the remaining Four Million Two
Hundred Thousand Dollars ($4,200,000) (“ Remaining Offering Amount”) of the Five Million Dollar ($5,000,000) Series B Convertible
Preferred Stock Offering (“ Offering”) pursuant to the same terms and conditions of the Offering; it is anticipated that the
Remaining Offering Amount will be received by the Company prior to the expiration of the Purchase Option. The Offering was conducted
pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (“ Securities
Act”). The investor entered into the subscription agreement (the “ Subscription Agreement”) with the Company and represented
in writing that he, she, or it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under
the Securities Act) and acquired the securities for his, her or its own account for investment purposes and any subsequent transfer or
sales of these securities will be in accordance with the Securities Act or exempt from registration under the Securities Act. The shares
of Series B Preferred Stock will be “restricted securities” under Rule 144 of the Securities Act, and certificates representing
the foregoing will bear a Rule 144 restrictive legend.

The
form of Subscription Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K, respectively, and the description in this
Current Report on Form 8-K of terms of Subscription Agreement are qualified in their entirety by reference to such exhibits.